QP96-24 Prescription Drug Electronic Prior Authorization (ePA) Submission Process Update

QP97-24 Commercial Pharmacy Benefit Exclusion for oxytocin, Pitocin® and Prepidil® Gel

QP95-24 Commercial Pharmacy Benefit Exclusion for lanreotide, Ultomiris® and Visudyne®

Commercial Pharmacy Program Policy Activity Provider Notification

MHCP Pharmacy Program Policy Activity Provider Notification

2025 Women's Preventive Contraceptive Benefits

2025 Detailed Description of Preventive Services

2025 Preventive Care Recommendations

2025 Preventive Prenatal Benefits

Notice of Privacy Practices

This notice describes how medical information about you may be used and disclosed, and how you can get access to this information. Please review this notice carefully.